Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.
MER Indicator |
MER description |
Target Fiscal Year |
Target |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female |
2015 |
30 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female |
2015 |
8 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female |
2015 |
30 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female |
2015 |
8 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male |
2015 |
30 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male |
2015 |
8 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male |
2015 |
30 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male |
2015 |
8 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female |
2015 |
330 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female |
2015 |
184 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female |
2015 |
330 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female |
2015 |
184 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male |
2015 |
325 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male |
2015 |
230 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male |
2015 |
325 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male |
2015 |
230 |
HTS_TST |
By Test Result: Negative |
2015 |
630 |
HTS_TST |
By Test Result: Negative |
2015 |
630 |
HTS_TST |
Number of individuals who received T&C services for HIV and received their test results during the past 12 months |
2015 |
715 |
HTS_TST |
Number of individuals who received T&C services for HIV and received their test results during the past 12 months |
2015 |
430 |
HTS_TST |
Number of individuals who received T&C services for HIV and received their test results during the past 12 months |
2015 |
715 |
HTS_TST |
Number of individuals who received T&C services for HIV and received their test results during the past 12 months |
2015 |
430 |
HTS_TST |
Sum of Aggregated Age/Sex <15 |
2015 |
16 |
HTS_TST |
Sum of Aggregated Age/Sex <15 |
2015 |
60 |
HTS_TST |
Sum of Aggregated Age/Sex <15 |
2015 |
16 |
HTS_TST |
Sum of Aggregated Age/Sex <15 |
2015 |
60 |
HTS_TST |
Sum of Aggregated Age/Sex 15+ |
2015 |
414 |
HTS_TST |
Sum of Aggregated Age/Sex 15+ |
2015 |
655 |
HTS_TST |
Sum of Aggregated Age/Sex 15+ |
2015 |
414 |
HTS_TST |
Sum of Aggregated Age/Sex 15+ |
2015 |
655 |
HTS_TST |
Sum of Aggregated Age/Sex disaggregates |
2015 |
430 |
HTS_TST |
Sum of Aggregated Age/Sex disaggregates |
2015 |
715 |
HTS_TST |
Sum of Aggregated Age/Sex disaggregates |
2015 |
430 |
HTS_TST |
Sum of Aggregated Age/Sex disaggregates |
2015 |
715 |
HTS_TST |
Sum of Test Result disaggregates |
2015 |
715 |
HTS_TST |
Sum of Test Result disaggregates |
2015 |
430 |
HTS_TST |
Sum of Test Result disaggregates |
2015 |
715 |
HTS_TST |
Sum of Test Result disaggregates |
2015 |
430 |
HTS_TST_POS |
By Test Result: Positive |
2015 |
85 |
HTS_TST_POS |
By Test Result: Positive |
2015 |
430 |
HTS_TST_POS |
By Test Result: Positive |
2015 |
85 |
HTS_TST_POS |
By Test Result: Positive |
2015 |
430 |
SITE_SUPP |
By program area/support type: Care and Support Direct Service Delivery (DSD) |
2015 |
3 |
SITE_SUPP |
By program area/support type: Care and Support Direct Service Delivery (DSD) |
2015 |
3 |
SITE_SUPP |
By program area/support type: Care and Support Technical Assistance-only (TA) |
2015 |
13 |
SITE_SUPP |
By program area/support type: Care and Support Technical Assistance-only (TA) |
2015 |
13 |
SITE_SUPP |
By program area/support type: HTC Direct Service Delivery (DSD) |
2015 |
7 |
SITE_SUPP |
By program area/support type: HTC Direct Service Delivery (DSD) |
2015 |
7 |
SITE_SUPP |
By program area/support type: HTC Technical Assistance-only (TA) |
2015 |
3 |
SITE_SUPP |
By program area/support type: HTC Technical Assistance-only (TA) |
2015 |
3 |
SITE_SUPP |
By program area/support type: TB/HIV Direct Service Delivery (DSD) |
2015 |
3 |
SITE_SUPP |
By program area/support type: TB/HIV Direct Service Delivery (DSD) |
2015 |
3 |
SITE_SUPP |
By program area/support type: Treatment Direct Service Delivery (DSD) |
2015 |
3 |
SITE_SUPP |
By program area/support type: Treatment Direct Service Delivery (DSD) |
2015 |
3 |
SITE_SUPP |
By program area/support type: Treatment Technical Assistance-only (TA) |
2015 |
13 |
SITE_SUPP |
By program area/support type: Treatment Technical Assistance-only (TA) |
2015 |
13 |
SITE_SUPP |
Number of unique sites supported by PEPFAR |
2015 |
45 |
SITE_SUPP |
Number of unique sites supported by PEPFAR |
2015 |
45 |
TX_CURR |
Aggregated Age/Sex: <1 Female |
2015 |
10 |
TX_CURR |
Aggregated Age/Sex: <1 Female |
2015 |
10 |
TX_CURR |
Aggregated Age/Sex: <1 Male |
2015 |
10 |
TX_CURR |
Aggregated Age/Sex: <1 Male |
2015 |
10 |
TX_CURR |
Aggregated Age/Sex: <15 Female |
2015 |
7,455 |
TX_CURR |
Aggregated Age/Sex: <15 Female |
2015 |
20 |
TX_CURR |
Aggregated Age/Sex: <15 Female |
2015 |
7,455 |
TX_CURR |
Aggregated Age/Sex: <15 Female |
2015 |
20 |
TX_CURR |
Aggregated Age/Sex: <15 Male |
2015 |
445 |
TX_CURR |
Aggregated Age/Sex: <15 Male |
2015 |
20 |
TX_CURR |
Aggregated Age/Sex: <15 Male |
2015 |
445 |
TX_CURR |
Aggregated Age/Sex: <15 Male |
2015 |
20 |
TX_CURR |
Aggregated Age/Sex: 15+ Female |
2015 |
380 |
TX_CURR |
Aggregated Age/Sex: 15+ Female |
2015 |
193 |
TX_CURR |
Aggregated Age/Sex: 15+ Female |
2015 |
380 |
TX_CURR |
Aggregated Age/Sex: 15+ Female |
2015 |
193 |
TX_CURR |
Aggregated Age/Sex: 15+ Male |
2015 |
10,920 |
TX_CURR |
Aggregated Age/Sex: 15+ Male |
2015 |
227 |
TX_CURR |
Aggregated Age/Sex: 15+ Male |
2015 |
10,920 |
TX_CURR |
Aggregated Age/Sex: 15+ Male |
2015 |
227 |
TX_CURR |
Number of adults and children receiving antiretroviral therapy (ART) |
2015 |
19,220 |
TX_CURR |
Number of adults and children receiving antiretroviral therapy (ART) |
2015 |
460 |
TX_CURR |
Number of adults and children receiving antiretroviral therapy (ART) |
2015 |
19,220 |
TX_CURR |
Number of adults and children receiving antiretroviral therapy (ART) |
2015 |
460 |
TX_CURR |
Sum of Aggregated Age/Sex <15 |
2015 |
7,900 |
TX_CURR |
Sum of Aggregated Age/Sex <15 |
2015 |
40 |
TX_CURR |
Sum of Aggregated Age/Sex <15 |
2015 |
7,900 |
TX_CURR |
Sum of Aggregated Age/Sex <15 |
2015 |
40 |
TX_CURR |
Sum of Aggregated Age/Sex 15+ |
2015 |
11,300 |
TX_CURR |
Sum of Aggregated Age/Sex 15+ |
2015 |
420 |
TX_CURR |
Sum of Aggregated Age/Sex 15+ |
2015 |
11,300 |
TX_CURR |
Sum of Aggregated Age/Sex 15+ |
2015 |
420 |
TX_CURR |
Sum of Aggregated Age/Sex disaggregates |
2015 |
19,200 |
TX_CURR |
Sum of Aggregated Age/Sex disaggregates |
2015 |
460 |
TX_CURR |
Sum of Aggregated Age/Sex disaggregates |
2015 |
19,200 |
TX_CURR |
Sum of Aggregated Age/Sex disaggregates |
2015 |
460 |
TX_CURR_NGI |
Aggregated Age/Sex: <1 Female |
2015 |
10 |
TX_CURR_NGI |
Aggregated Age/Sex: <1 Female |
2015 |
10 |
TX_CURR_NGI |
Aggregated Age/Sex: <1 Male |
2015 |
10 |
TX_CURR_NGI |
Aggregated Age/Sex: <1 Male |
2015 |
10 |
TX_CURR_NGI |
Aggregated Age/Sex: <15 Female |
2015 |
400 |
TX_CURR_NGI |
Aggregated Age/Sex: <15 Female |
2015 |
400 |
TX_CURR_NGI |
Aggregated Age/Sex: <15 Male |
2015 |
465 |
TX_CURR_NGI |
Aggregated Age/Sex: <15 Male |
2015 |
465 |
TX_CURR_NGI |
Aggregated Age/Sex: 15+ Female |
2015 |
7,645 |
TX_CURR_NGI |
Aggregated Age/Sex: 15+ Female |
2015 |
7,645 |
TX_CURR_NGI |
Aggregated Age/Sex: 15+ Male |
2015 |
11,150 |
TX_CURR_NGI |
Aggregated Age/Sex: 15+ Male |
2015 |
11,150 |
TX_CURR_NGI |
Number of adults and children receiving antiretroviral therapy (ART) |
2015 |
19,680 |
TX_CURR_NGI |
Number of adults and children receiving antiretroviral therapy (ART) |
2015 |
19,680 |
TX_CURR_NGI |
Sum of Aggregated Age/Sex <15 |
2015 |
865 |
TX_CURR_NGI |
Sum of Aggregated Age/Sex <15 |
2015 |
865 |
TX_CURR_NGI |
Sum of Aggregated Age/Sex 15+ |
2015 |
18,795 |
TX_CURR_NGI |
Sum of Aggregated Age/Sex 15+ |
2015 |
18,795 |
TX_CURR_NGI |
Sum of Aggregated Age/Sex disaggregates |
2015 |
19,660 |
TX_CURR_NGI |
Sum of Aggregated Age/Sex disaggregates |
2015 |
19,660 |
TX_RET |
Number of adults and children who are still alive and on treatment at 12 months after initiating ART |
2015 |
240 |
TX_RET |
Number of adults and children who are still alive and on treatment at 12 months after initiating ART |
2015 |
240 |
TX_RET |
Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up |
2015 |
300 |
TX_RET |
Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up |
2015 |
300 |
TX_SITE |
By support type: Direct Service Delivery (DSD): Number of PEPFAR-supported ART sites with a retention rate of 75% or greater for patients 12 months after ART initiation |
2015 |
1 |
TX_SITE |
By support type: Direct Service Delivery (DSD): Number of PEPFAR-supported ART sites with a retention rate of 75% or greater for patients 12 months after ART initiation |
2015 |
1 |
TX_SITE |
By support type: Direct Service Delivery (DSD): Total number of PEPFAR-supported ART sites |
2015 |
3 |
TX_SITE |
By support type: Direct Service Delivery (DSD): Total number of PEPFAR-supported ART sites |
2015 |
3 |
TX_SITE |
By support type: Technical Assistance (TA-only): Number of PEPFAR-supported ART sites with a retention rate of 75% or greater for patients 12 months after ART initiation |
2015 |
13 |
TX_SITE |
By support type: Technical Assistance (TA-only): Number of PEPFAR-supported ART sites with a retention rate of 75% or greater for patients 12 months after ART initiation |
2015 |
13 |
TX_SITE |
By support type: Technical Assistance (TA-only): Total number of PEPFAR-supported ART sites |
2015 |
13 |
TX_SITE |
By support type: Technical Assistance (TA-only): Total number of PEPFAR-supported ART sites |
2015 |
13 |
TX_SITE |
Number of PEPFAR-supported ART sites with a retention rate of 75% or greater for patients 12 months after ART initiation |
2015 |
14 |
TX_SITE |
Number of PEPFAR-supported ART sites with a retention rate of 75% or greater for patients 12 months after ART initiation |
2015 |
14 |
TX_SITE |
Sum of Numerator Site Support Type disaggregates |
2015 |
14 |
TX_SITE |
Sum of Numerator Site Support Type disaggregates |
2015 |
14 |
TX_SITE |
Total number of PEPFAR-supported ART sites |
2015 |
16 |
TX_SITE |
Total number of PEPFAR-supported ART sites |
2015 |
16 |
TX_SITE_den |
Sum of Denominator Site Support Type disaggregates |
2015 |
16 |
TX_SITE_den |
Sum of Denominator Site Support Type disaggregates |
2015 |
16 |